Hints and tips:
...Most big pharmaceutical and medtech companies have operations in the country, which produces some 40 per cent of the world’s contact lenses, as well as all the world’s Botox and a key ingredient used in Viagra...
...Although the erectile dysfunction treatment has faced competition from cheaper generic alternatives since December, some patients and doctors still prefer the Pfizer version....
...The US drugmaker is expected to spin-off the new unit to create a much larger seller of off-patent and generic medicines, including former blockbuster brands Lipitor and Viagra....
...This is best known for manufacturing generic drugs, as well as Epipens. Mylan shares have fallen by more than half in the past two years.* The generics sector has lost much of its pricing power....
...The all-stock merger announced on Monday will bring under one roof former branded blockbusters such as Lipitor and Viagra with Mylan’s pipeline of new generics and biosimilars, expanding the businesses’...
...Pfizer is then expected to spin-off the new unit to create an off-patent and generic medicines business, including former blockbuster brands Lipitor and Viagra....
...Pfizer’s move to spin off an off-patent unit whose assets include Viagra perked us up more. The US drugmaker is reversing the division into quoted generics group Mylan, gaining majority control....
...The all-stock merger announced on Monday will bring under one roof former branded blockbusters such as Lipitor and Viagra with Mylan’s pipeline of new generic drugs....
...The company behind Viagra and Lipitor said its forecast for full-year adjusted earnings — at between $2.82 to $2.92 per diluted share — would be about 6 cents higher if the currency headwind were stripped...
...Lex hits the spot on Pfizer’s deal with Mylan, which will see the drugmaker spin off its Upjohn unit and combine it with the maker of generic drugs....
...The company attributed the less optimistic outlook to lower than expected revenues from its so-called Essential Health unit — which includes legacy brands like Lipitor and Viagra, that have already lost...
...(Stat, Nature, FT video) Insulin prices Eli Lilly said it would launch a much cheaper generic version of Humalog, its popular insulin drug, in a sign of the political pressure on US drugmakers....
...By comparison, the cost has plummeted by almost 90 per cent since generic alternatives came on to the market in 2013....
...(NBC) Generic shenanigans The makers of the brand-name drugs cited by the Trump administration for “shenanigans” preventing generic competition, have increased prices by double-digit percentages since 2012...
...A 100mg tablet of Viagra went from $57.94 to $80.82 over the same period — an increase of 39 per cent — although a generic version of the medicine has been available since December....
...That follows earlier campaigns at Dutch paint maker Akzo Nobel and German generic Viagra manufacturer Stada....
...Stada, the maker of generic Viagra, said it expected both its executive and supervisory boards “to be able to recommend the renewed offer for acceptance to the shareholders”....
...Executives point to the success of recent auctions, including the sale of Stada, the German maker of generic Viagra, which was acquired by Cinven and Bain Capital, two buyout funds....
...Viagra maker Stada....
...The private equity groups contacted generic Viagra maker Stada, and German regulator BaFin, to secure the waiver....
...The two private equity bidders have agreed to buy 63.85 per cent of all outstanding shares in Stada, which makes a copycat version of Viagra....
...Europe’s largest buyout in four years has been given the all clear after a private equity consortium cleared a threshold to purchase Stada, the German maker of generic Viagra....
...The drawn-out sale process has created difficulties for Stada, which produces generic copies of drugs such as Viagra....
...Bain and Cinven have yet to receive clearance from BaFin and Stada but those approvals may come in the next 48 hours, allowing them to make a new offer valuing the maker of generic Viagra at the same €66...
...The private equity consortium bidding for the maker of copycat drugs such as generic Viagra has secured an exemption from a one-year exclusion period, meaning it can submit a renewed voluntary public takeover...
International Edition